Shida Kyoko, Suzuki Toshiyasu, Sugahara Kazuhiro, Sobue Kazuya
Masui. 2016 May;65(5):542-7.
In the case of medication errors which are among the more frequent adverse events that occur in the hospital, there is a need for effective measures to prevent incidence. According to the Japan Society of Anesthesiologists study "Drug incident investigation 2005-2007 years", "Error of a syringe at the selection stage" was the most frequent (44.2%). The status of current measures and best practices implemented in Japanese hospitals was the focus of a subsequent investigation.
Representative specialists in anesthesiology certified hospitals across the country were surveyed via a questionnaire sampling that lasted 46 days. Investigation method was via the Web with survey responses anonymous.
With respect to preventive measures implemented to mitigate risk of medication errors in perioperative settings, responses included: incident and accident report (215 facilities, 70.3%), use of pre-filled syringes (180 facilities, 58.8%), devised the arrangement of dangerous drugs (154 facilities, 50.3%), use of the product with improper connection preventing mechanism (123 facilities, 40.2%), double-check (116 facilities, 37.9%), use of color barreled syringe (115 facilities, 37.6%), use of color label or color tape (89 facilities, 29.1%), presentation of medication such as placing the ampoule or syringe on a tray by dividing color code for drug class on a tray (54 facilities, 17.6%), the discontinuance of handwritten labels (23 facilities, 7.5%), use of a drug verification system that uses bar code (20 facilities, 6.5%), and facilities that have not implemented any means (11 facilities, 3.6%), others not mentioned (10 facilities, 3.3%), and use of carts that count/account the agents by drug type and record selection and number picked automatically (6 facilities, 2.0%). Drug name identification affixed to the syringe via perforated label torn from the ampoule/vial, etc. (245 facilities, 28.1%), handwriting directly to the syringe (208 facilities, 23.8%), use of the attached label (like that comes with the product) (187 facilities, 21.4%), handwriting on the plain tape (87 facilities, 10.0%), printing labels (62 facilities, 7.1%), printed color labels (44 facilities, 5.0%), handwriting on the color tape (27 facilities, 3.1%), machinery for printing the drug name by scanning bar code of the ampoule, etc.(10 facilities, 1.1%), others (3 facilities, 0.3%), no description on the prepared drug (0 facilities, 0%). The awareness of international standard color code, such as by the International Organization for Standardization (ISO), was only 18.6%.
Targeting anesthesiology certified hospitals recognized by the Japan Society of Anesthesiologists, the result of the survey on the measures to prevent medication errors during perioperative procedures indicated that various measures were documented in use. However, many facilities still use hand written labels (a common cause for errors). Confirmation of the need for improved drug name and drug recognition on syringe was documented.
用药错误是医院中较为常见的不良事件之一,需要采取有效措施来预防其发生。根据日本麻醉医师协会的研究《2005 - 2007年药物事件调查》,“选择阶段的注射器错误”最为常见(44.2%)。随后的一项调查重点关注了日本医院目前采取的措施和最佳实践情况。
通过为期46天的问卷调查,对全国麻醉专业认证医院的代表性专家进行了调查。调查方式为网络调查,调查回复匿名。
关于在围手术期采取的减轻用药错误风险的预防措施,回复包括:事件和事故报告(215家机构,70.3%)、使用预填充注射器(180家机构,58.8%)、设计危险药物的摆放方式(154家机构,50.3%)、使用带有防止不当连接机制的产品(123家机构,40.2%)、双人核对(116家机构,37.9%)、使用彩色桶装注射器(115家机构,37.6%)、使用彩色标签或色带(89家机构,29.1%)、通过在托盘上按药物类别划分颜色代码来摆放安瓿或注射器等方式展示药物(54家机构,17.6%)、停止使用手写标签(23家机构,7.5%)、使用基于条形码的药物验证系统(20家机构,6.5%)、未实施任何措施的机构(11家机构,3.6%)、未提及的其他措施(10家机构,3.3%)以及使用能按药物类型计数/记录并自动记录所选药物及其数量的推车(6家机构,2.0%)。通过从安瓿/小瓶等撕下的穿孔标签粘贴在注射器上进行药物名称标识(245家机构,28.1%)、直接手写在注射器上(208家机构,23.8%)、使用附带标签(如产品自带的标签)(187家机构,21.4%)、手写在普通胶带上(87家机构,10.0%)、打印标签(62家机构,7.1%)、打印彩色标签(44家机构,5.0%)、手写在彩色胶带上(27家机构,3.1%)、通过扫描安瓿等的条形码来打印药物名称的机器(10家机构,1.1%)、其他(3家机构,0.3%)、未对已准备好的药物进行描述(0家机构,0%)。对国际标准化组织(ISO)等国际标准颜色代码的知晓率仅为18.6%。
以日本麻醉医师协会认可的麻醉专业认证医院为对象,关于围手术期预防用药错误措施的调查结果表明,已记录了多种正在使用的措施。然而,许多机构仍在使用手写标签(这是错误的常见原因)。已记录了对改进注射器上药物名称和药物识别的需求。